Reasonable Timing of Radiotherapy for Stage IV Non-Small-Cell Lung Cancer During Targeted Therapy Based on Tumour Volume Change

PURPOSE: The aim of this study was to investigate the reasonable timing of radiotherapy for stage IV non-small-cell lung cancer (NSCLC) with EGFR-positive mutations during targeted therapy based on tumour volume change (TVC). PATIENTS AND METHODS: Simulation Computed Tomography Scan (SCTS) measureme...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qingsong, Liang, Na, Zhang, Xia, Zhang, Yi, Ouyang, Weiwei, Su, Shengfa, Ma, Zhu, Hu, Yinxiang, Geng, Yichao, Chen, Xiaxia, Lu, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496348/
https://www.ncbi.nlm.nih.gov/pubmed/34631535
http://dx.doi.org/10.3389/fonc.2021.705303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496348/
https://www.ncbi.nlm.nih.gov/pubmed/34631535
http://dx.doi.org/10.3389/fonc.2021.705303

Ejemplares similares